Phone apps nearly 3 times as good as no/basic support for quitting smoking long term

If high quality clinical trials confirm lasting benefits and key features, apps could become cornerstone of global tobacco control efforts, suggest researchers Smartphone apps—particularly those based on psychological theories—are 3 times as effective as no/minimal support at helping people who smoke stub out their tobacco use long term, suggests a ...

2026-01-14T09:39:54+00:0014 January 2026|BMJ Evidence Based Medicine, Press release|

Little awareness of medical + psychological complexities of steroid cream withdrawal

Condition often poorly recognised, diagnosed, managed and researched, say report authors This has prompted unfounded fears, particularly on social media, that all steroids are harmful There is little awareness, particularly among clinicians, of the medical and psychological complexities of ‘topical steroid withdrawal’—the body’s adverse response to the prolonged use of ...

2025-12-17T09:38:48+00:0017 December 2025|BMJ Case Reports, Press release|

Less than half of schoolkids at risk of food anaphylaxis in England prescribed adrenaline ‘antidote’

Yet UK and European drug regulators specify access to 2 adrenaline devices at all times Giving ‘spare’ devices to all schools would be safer and save local health bodies £millions Less than half of schoolchildren in England who are at risk of a serious and potentially life-threatening allergic reaction (anaphylaxis) ...

2025-10-22T08:43:31+00:0022 October 2025|Press release|

SGLT-2 diabetes drugs linked to lower risk of autoimmune diseases 

Replication in other populations and settings needed to confirm and extend these observations, say researchers Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group of diabetes drugs called ...

2025-10-16T09:27:42+00:0016 October 2025|Press release, The BMJ|

Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain

While it likely increases the risk of serious side effects, including heart disease Potential harms probably outweigh benefits, and use should be minimised, say researchers The strong opioid painkiller, tramadol, is not that effective at easing chronic pain for which it’s widely prescribed, finds a pooled data analysis of the ...

2025-10-08T11:34:44+00:008 October 2025|BMJ Evidence Based Medicine, Press release|
Go to Top